Product Dossier

EBGLYSS

Product Dossier for EBGLYSS (lebrikizumab, Eli Lilly). ARTG record, PBS listing, PBAC outcomes, AusPAR — compiled by arcimedes.

• Sponsor: Eli Lilly
• Active ingredient: lebrikizumab
• Therapeutic area: Dermatology
• Same area: DIPROSONE
• Same area: ENSTILAR

AusPAR (TGA)